Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Nearly a day after being downgraded from a tropical storm, Ophelia still threatened parts of the Northeast on Sunday with coastal flooding, life-threatening waves and heavy rain from Washington to New York City, the National Hurricane Center said.
Surgeons have transplanted a pig’s heart into a dying man in a bid to prolong his life – only the second patient to ever undergo such an experimental feat. Two days later, the man was cracking jokes and able to sit in a chair, Maryland doctors said Friday.
Tropical Storm Ophelia formed off the mid-Atlantic coast and was expected to bring heavy rain, storm surge and windy conditions over the weekend, the National Hurricane Center said Friday.
A storm churning in waters off the eastern U.S. has increased to tropical storm strength and is forecast to reach the North Carolina coast Friday morning, the National Hurricane Center said.
